Evotec AG has signed a Share Purchase Agreement to acquire the remaining 30% of its Joint Venture with DIL Ltd., India for $2.3 million. The acquisition gives Evotec 100% ownership of this subsidiary. Evotec had acquired 70% of the equity in August 2009. The transaction is expected to close October 4th. Evotec India operates out of Thane, Mumbai, and employs 140 scientists focusing primarily on Medicinal Chemistry. The company plans to further expand capacity. Colin Bond, chief financial offic...